A patient and public involvement (PPI) toolkit for meaningful and flexible involvement in clinical trials – a work in progress

被引:92
|
作者
Bagley H.J. [1 ]
Short H. [1 ]
Harman N.L. [1 ]
Hickey H.R. [1 ]
Gamble C.L. [1 ]
Woolfall K. [2 ]
Young B. [2 ]
Williamson P.R. [1 ]
机构
[1] Department of Biostatistics, Clinical Trials Research Centre, Institute of Translational Medicine, University of Liverpool, Liverpool
[2] Institute of Psychology, Health and Society, University of Liverpool, Liverpool
基金
英国医学研究理事会;
关键词
Clinical Trials; Patient and public involvement; Research; Toolkit;
D O I
10.1186/s40900-016-0029-8
中图分类号
学科分类号
摘要
Background Patient and public involvement (PPI) in research is increasingly a funder requirement due to the potential benefits in the design of relevant, participant friendly, ethically sound research. The use and sharing of resources can benefit PPI, but available resources are not consistently used leading to duplication of effort. This paper describes a developing toolkit to support clinical trials teams to undertake effective and meaningful PPI. Methods The first phase in developing the toolkit was to describe which PPI activities should be considered in the pathway of a clinical trial and at what stage these activities should take place. This pathway was informed through review of the type and timing of PPI activities within trials coordinated by the Clinical Trials Research Centre and previously described areas of potential PPI impact in trials. In the second phase, key websites around PPI and identification of resources opportunistically, e.g. in conversation with other trialists or social media, were used to identify resources. Tools were developed where gaps existed. Results A flowchart was developed describing PPI activities that should be considered in the clinical trial pathway and the point at which these activities should happen. Three toolkit domains were identified: planning PPI; supporting PPI; recording and evaluating PPI. Four main activities and corresponding tools were identified under the planning for PPI: developing a plan; identifying patient and public contributors; allocating appropriate costs; and managing expectations. In supporting PPI, tools were developed to review participant information sheets. These tools, which require a summary of potential trial participant characteristics and circumstances help to clarify requirements and expectations of PPI review. For recording and evaluating PPI, the planned PPI interventions should be monitored in terms of impact, and a tool to monitor public contributor experience is in development. Conclusions This toolkit provides a developing ‘off the shelf’ resource to support trial teams with limited resources in undertaking PPI. Key activities in further developing and maintaining the toolkit are to: listen to the views and experience of both research teams and public contributors using the tools, to identify the need for future tools, to modify tools based on experience of their use; to update the toolkit based on any newly identified resources that come to light; to raise awareness of the toolkit and to work in collaboration with others to both develop and test out PPI resources in order to reduce duplication of work in PPI. © 2016 Bagley et al.
引用
收藏
相关论文
共 50 条
  • [1] Developing a toolkit for patient and public involvement in a clinical trials unit
    Heather Bagley
    Nicola Harman
    Kerry Woolfall
    Bridget Young
    Hannah Short
    Helen Hickey
    Paula Williamson
    [J]. Trials, 16
  • [2] Developing a toolkit for patient and public involvement in a clinical trials unit
    Bagley, Heather
    Harman, Nicola
    Woolfall, Kerry
    Young, Bridget
    Short, Hannah
    Hickey, Helen
    Williamson, Paula
    [J]. TRIALS, 2015, 16
  • [3] Patient and public involvement (PPI) in trial oversight: an ethnographic study of eight clinical trials
    Coulman, Karen
    Nicholson, Alex
    Shaw, Alison
    Daykin, Anne
    Cramer, Helen
    Gamble, Carrol
    Macefield, Rhiannon
    Pick, Malcolm E.
    Selman, Lucy
    Shorter, Gillian W.
    Sydes, Matt R.
    Taylor, Gordon
    Lane, J. Athene
    [J]. TRIALS, 2019, 20
  • [4] A Systematic Review of Patient and Public Involvement (PPI) in Bariatric Research Trials: The Need for More Work
    Aya Musbahi
    Danielle Clyde
    Peter Small
    Michael Courtney
    Kamal Mahawar
    Peter J. Lamb
    Andrew G. N. Robertson
    [J]. Obesity Surgery, 2022, 32 : 3740 - 3751
  • [5] A Systematic Review of Patient and Public Involvement (PPI) in Bariatric Research Trials: The Need for More Work
    Musbahi, Aya
    Clyde, Danielle
    Small, Peter
    Courtney, Michael
    Mahawar, Kamal
    Lamb, Peter J.
    Robertson, Andrew G. N.
    [J]. OBESITY SURGERY, 2022, 32 (11) : 3740 - 3751
  • [6] Developing meaningful public involvement in a cancer clinical trials unit
    Jessica Baillie
    Jim Fitzgibbon
    Natalie Simon
    Annmarie Nelson
    [J]. Trials, 16
  • [7] Developing meaningful public involvement in a cancer clinical trials unit
    Baillie, Jessica
    Fitzgibbon, Jim
    Simon, Natalie
    Nelson, Annmarie
    [J]. TRIALS, 2015, 16
  • [8] Patient and Public Involvement (PPI) in outcome selection in breast cancer and nephrology trials
    Ciara Buckley
    Shaun Treweek
    Lynn Laidlaw
    Frances Shiely
    [J]. Trials, 24
  • [9] Patient and Public Involvement (PPI) in outcome selection in breast cancer and nephrology trials
    Buckley, Ciara
    Treweek, Shaun
    Laidlaw, Lynn
    Shiely, Frances
    [J]. TRIALS, 2023, 24 (01)
  • [10] PIRRIST: Patient and public involvement (PPI) to enhance recruitment and retention in surgical trials
    Crocker, Joanna C.
    Bostock, Jennifer
    Treweek, Shaun
    Farrar, Nicola
    Chant, Alan
    Cook, Jonathan A.
    Kerr, Polly
    Rees, Sian
    Locock, Louise
    Woolfall, Kerry
    Olszowski, Sophie
    Bulbulia, Richard
    [J]. TRIALS, 2019, 20